Content Type: Whitepaper/Executive Summary
This executive summary discusses in vitro methodologies used at Lonza for the characterization of bioavailability enhancing formulations, as well as criteria for selecting the right in vitro method based on compound properties and dose. To learn more, please download our executive summary.
Latest content